The School of Chemistry and Molecular Biosciences (SCMB) is a distinguished multidisciplinary school for teaching and research that encompasses the traditional academic disciplines of Chemistry, Biochemistry, Molecular Biology, Microbiology and Parasitology. The School is well equipped for contemporary molecular genetics and cell biology research, and is supported by the University’s outstanding molecular bioscience infrastructure, including confocal microscopy, proteomics, microarray and transgenic animal facilities. The School houses over 50 academic staff and their research groups, with strong national and international profile and sustained high level success in competitive grant funding.
The research group is headed by Associate Professor Melissa Brown and is interested in the transcriptional and epigenetic regulation of gene expression, and mammary gland and breast cancer biology. Current studies include transcriptional, post-transcriptional and epigenetic regulation of breast cancer associated genes, molecular and cellular consequences of Brca1 disruption in mammary epithelial cells and functional evaluation of unclassified sequence variants in breast cancer predisposing genes. The laboratory is a spacious modern molecular biology laboratory with equipment including PCR, real-time PCR, high-resolution melt, luminometer, robotic DNA, RNA and protein extraction workstation, and a fully equipped tissue culture room, and access to confocal microscopy, proteomics, microarray and transgenic animal facilities.The group is funded by NHMRC, ARC and Cancer Councils, and has strong links with the Queensland Institute of Medical Research and the Diamantina Institute for Cancer, Immunology and Metabolic Medicine.
The specific project focuses on the identification of genetic and epigenetic biomarkers of advanced breast cancer and is funded by Cancer Australia
The role of the postdoctoral fellows will be to identify novel regulatory elements in breast cancer associated genes and determine their potential to be biomarkers of advanced breast cancer. They will present their results on a regular basis at national and international conferences and in high quality peer-reviewed journals and maintain a strong awareness of the literature. They will also contribute to regular laboratory meetings, to training students and to aspects of lab management.
Applicants must have a PhD in cancer molecular biology or genetics, accompanied by high quality peer-reviewed first author publications and recommendations from their postgraduate or postdoctoral advisor. Experience in modern molecular biology techniques is essential. A high level of motivation and independence is expected.
This is a full-time, fixed term appointment initially for 1 year at Research Academic Level A, with the possibility of renewal. The remuneration package will be in the range $64,063 – $68,768 p.a., plus employer superannuation contributions of 17% (total package will be in the range $74,953 - $80,458 p.a.).
The University of Queensland (UQ) is one of Australia's premier learning and research institutions. It is the oldest university in Queensland and has produced generations of graduates who have gone on to become leaders in all areas of society and industry. The University is a founding member of the national Group of Eight, an alliance of research-strong "sandstone" universities committed to ensuring that Australia has higher education institutions which are genuinely world class. It belongs also to the global Universitas 21 alliance. This group aims to enhance the quality of university outcomes through international benchmarking and a joint venture e-learning project with The Thomson Corporation.
The research group is headed by Associate Professor Melissa Brown and is interested in the transcriptional and epigenetic regulation of gene expression, and mammary gland and breast cancer biology. Current studies include transcriptional, post-transcriptional and epigenetic regulation of breast cancer associated genes, molecular and cellular consequences of Brca1 disruption in mammary epithelial cells and functional evaluation of unclassified sequence variants in breast cancer predisposing genes. The laboratory is a spacious modern molecular biology laboratory with equipment including PCR, real-time PCR, high-resolution melt, luminometer, robotic DNA, RNA and protein extraction workstation, and a fully equipped tissue culture room, and access to confocal microscopy, proteomics, microarray and transgenic animal facilities.The group is funded by NHMRC, ARC and Cancer Councils, and has strong links with the Queensland Institute of Medical Research and the Diamantina Institute for Cancer, Immunology and Metabolic Medicine.
The specific project focuses on the identification of genetic and epigenetic biomarkers of advanced breast cancer and is funded by Cancer Australia
The role of the postdoctoral fellows will be to identify novel regulatory elements in breast cancer associated genes and determine their potential to be biomarkers of advanced breast cancer. They will present their results on a regular basis at national and international conferences and in high quality peer-reviewed journals and maintain a strong awareness of the literature. They will also contribute to regular laboratory meetings, to training students and to aspects of lab management.
Applicants must have a PhD in cancer molecular biology or genetics, accompanied by high quality peer-reviewed first author publications and recommendations from their postgraduate or postdoctoral advisor. Experience in modern molecular biology techniques is essential. A high level of motivation and independence is expected.
This is a full-time, fixed term appointment initially for 1 year at Research Academic Level A, with the possibility of renewal. The remuneration package will be in the range $64,063 – $68,768 p.a., plus employer superannuation contributions of 17% (total package will be in the range $74,953 - $80,458 p.a.).
The University of Queensland (UQ) is one of Australia's premier learning and research institutions. It is the oldest university in Queensland and has produced generations of graduates who have gone on to become leaders in all areas of society and industry. The University is a founding member of the national Group of Eight, an alliance of research-strong "sandstone" universities committed to ensuring that Australia has higher education institutions which are genuinely world class. It belongs also to the global Universitas 21 alliance. This group aims to enhance the quality of university outcomes through international benchmarking and a joint venture e-learning project with The Thomson Corporation.